Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649
DNA Damage Sensing by the ATM and ATR Kinases
Marechal, A., & Zou, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012716 · Cited by 1,514
“The activation of ATM by DSBs leads to the phosphorylation of a number of substrates, such as Brca1, Chk2, and p53, mediating the effects of ATM on DNA repair, cell-cycle arrest, apoptosis, and other downstream processes (Shiloh 2003; Lavin 2008).”
BackgroundThe ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
(2010) · Advances in Cancer Research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,276
ATM Activation by Oxidative Stress
Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D., & Paull, T. T. (2010) · Science · doi:10.1126/science.1192912 · Cited by 1,079
Self-citationCell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand Breaks
Shanbhag, N. M., Rafalska-Metcalf, I. U., Balane-Bolivar, C., Janicki, S. M., & Greenberg, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.04.038 · Cited by 737
Lukas, C., Savic, V., Bekker-Jensen, S., Doil, C., Neumann, B., Sølvhøj Pedersen, R., Grøfte, M., Chan, K. L., Hickson, I. D., Bartek, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2201 · Cited by 667
ATM and ATR as therapeutic targets in cancer
Weber, A. M., & Ryan, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.001 · Cited by 635
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 608
Chromatin Remodeling at DNA Double-Strand Breaks
Price, B. D., & D’Andrea, A. D. (2013) · Cell · doi:10.1016/j.cell.2013.02.011 · Cited by 588
“The MRN complex, consisting of the mre11, rad50, and nbs1 proteins, is first recruited to DSBs, where it functions to recruit and activate the ATM protein kinase (Lavin, 2008; Sun et al., 2010).”
From pathogenesis to treatment of chronic lymphocytic leukaemia
Zenz, T., Mertens, D., Küppers, R., Döhner, H., & Stilgenbauer, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2764 · Cited by 553
Plimack, E. R., Dunbrack, R. L., Brennan, T. A., Andrake, M. D., Zhou, Y., Serebriiskii, I. G., Slifker, M., Alpaugh, K., Dulaimi, E., Palma, N., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.07.009 · Cited by 519
ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491
Inflammation-induced DNA damage, mutations and cancer
Kay, J., Thadhani, E., Samson, L., & Engelward, B. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102673 · Cited by 464
Paull, T. T. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034335 · Cited by 460
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
The GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group, & The Wellcome Trust Case Control Consortium 2 (2011) · Nature Genetics · doi:10.1038/ng.735 · Cited by 432
Notarangelo, L. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.053 · Cited by 417
Moyal, L., Lerenthal, Y., Gana-Weisz, M., Mass, G., So, S., Wang, S.-Y., Eppink, B., Chung, Y. M., Shalev, G., Shema, E., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.015 · Cited by 403
Golding, S. E., Rosenberg, E., Valerie, N., Hussaini, I., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L., Menear, K. A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0519 · Cited by 385
Mitochondrial dysfunction in ataxia-telangiectasia
Valentin-Vega, Y. A., MacLean, K. H., Tait-Mulder, J., Milasta, S., Steeves, M., Dorsey, F. C., Cleveland, J. L., Green, D. R., & Kastan, M. B. (2012) · Blood · doi:10.1182/blood-2011-08-373639 · Cited by 365
Thompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357
Methodologies for Improving HDR Efficiency
Liu, M., Rehman, S., Tang, X., Gu, K., Fan, Q., Chen, D., & Ma, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00691 · Cited by 323
Noon, A. T., Shibata, A., Rief, N., Löbrich, M., Stewart, G. S., Jeggo, P. A., & Goodarzi, A. A. (2010) · Nature Cell Biology · doi:10.1038/ncb2017 · Cited by 339
The ATM protein kinase and cellular redox signaling: beyond the DNA damage response
Ditch, S., & Paull, T. T. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 324
Goodarzi, A. A., Jeggo, P., & Lobrich, M. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.013 · Cited by 305
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Weston, V. J., Oldreive, C. E., Skowronska, A., Oscier, D. G., Pratt, G., Dyer, M. J. S., Smith, G., Powell, J. E., Rudzki, Z., Kearns, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-265769 · Cited by 300
Cellular functions of the protein kinase ATM and their relevance to human disease
Lee, J.-H., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 289
ATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.169730 · Cited by 271
Osorio, F. G., Bárcena, C., Soria-Valles, C., Ramsay, A. J., de Carlos, F., Cobo, J., Fueyo, A., Freije, J. M. P., & López-Otín, C. (2012) · Genes & Development · doi:10.1101/gad.197954.112 · Cited by 276
ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage
Bensimon, A., Schmidt, A., Ziv, Y., Elkon, R., Wang, S.-Y., Chen, D. J., Aebersold, R., & Shiloh, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2001034 · Cited by 280
Boboila, C., Alt, F. W., & Schwer, B. (2012) · Advances in Immunology · doi:10.1016/b978-0-12-394300-2.00001-6 · Cited by 273
DNA Damage Response: Three Levels of DNA Repair Regulation
Sirbu, B. M., & Cortez, D. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012724 · Cited by 272
ATM is down-regulated by N-Myc–regulated microRNA-421
Hu, H., Du, L., Nagabayashi, G., Seeger, R. C., & Gatti, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907763107 · Cited by 260
Multiple roles of ATM in monitoring and maintaining DNA integrity
Derheimer, F. A., & Kastan, M. B. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.031 · Cited by 256
DNA damage‐dependent NF‐κB activation: NEMO turns nuclear signaling inside out
McCool, K. W., & Miyamoto, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01101.x · Cited by 250
Yan, S., Sorrell, M., & Berman, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1666-4 · Cited by 247
Genome-wide association study identifies three new melanoma susceptibility loci
Barrett, J. H., Iles, M. M., Harland, M., Taylor, J. C., Aitken, J. F., Andresen, P. A., Akslen, L. A., Armstrong, B. K., Avril, M.-F., Azizi, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.959 · Cited by 240
ATM and the Molecular Pathogenesis of Ataxia Telangiectasia
McKinnon, P. J. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132509 · Cited by 240
Squatrito, M., Brennan, C. W., Helmy, K., Huse, J. T., Petrini, J. H., & Holland, E. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.034 · Cited by 238
Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage Response
Bennetzen, M. V., Larsen, D. H., Bunkenborg, J., Bartek, J., Lukas, J., & Andersen, J. S. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900616-mcp200 · Cited by 236
The DNA Damage Response Induces IFN
Brzostek-Racine, S., Gordon, C., Van Scoy, S., & Reich, N. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100040 · Cited by 234
Tip60: Connecting chromatin to DNA damage signaling
Sun, Y., Jiang, X., & Price, B. D. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10931 · Cited by 230
Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation
Yan, D., Ng, W. L., Zhang, X., Wang, P., Zhang, Z., Mo, Y.-Y., Mao, H., Hao, C., Olson, J. J., Curran, W. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011397 · Cited by 227
Yogev, O., Yogev, O., Singer, E., Shaulian, E., Goldberg, M., Fox, T. D., & Pines, O. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000328 · Cited by 220
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Biddlestone-Thorpe, L., Sajjad, M., Rosenberg, E., Beckta, J. M., Valerie, N. C. K., Tokarz, M., Adams, B. R., Wagner, A. F., Khalil, A., Gilfor, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3408 · Cited by 213
Hurov, K. E., Cotta-Ramusino, C., & Elledge, S. J. (2010) · Genes & Development · doi:10.1101/gad.1934210 · Cited by 210
Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response
Salton, M., Lerenthal, Y., Wang, S.-Y., Chen, D. J., & Shiloh, Y. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11298 · Cited by 212
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 207
Barascu, A., Le Chalony, C., Pennarun, G., Genet, D., Imam, N., Lopez, B., & Bertrand, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.492 · Cited by 206
Jinadasa, R. N., Bloom, S. E., Weiss, R. S., & Duhamel, G. E. (2011) · Microbiology · doi:10.1099/mic.0.049536-0 · Cited by 212
Autophosphorylation and ATM Activation
Kozlov, S. V., Graham, M. E., Jakob, B., Tobias, F., Kijas, A. W., Tanuji, M., Chen, P., Robinson, P. J., Taucher-Scholz, G., Suzuki, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204065 · Cited by 197
Self-citationATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
Williamson, C. T., Muzik, H., Turhan, A. G., Zamò, A., O'Connor, M. J., Bebb, D. G., & Lees-Miller, S. P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0872 · Cited by 193
Ataxia‐telangiectasia: A review of clinical features and molecular pathology
Amirifar, P., Ranjouri, M. R., Yazdani, R., Abolhassani, H., & Aghamohammadi, A. (2019) · Pediatric Allergy and Immunology · doi:10.1111/pai.13020 · Cited by 187
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
Dedes, K. J., Wilkerson, P. M., Wetterskog, D., Weigelt, B., Ashworth, A., & Reis-Filho, J. S. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15273 · Cited by 191
MicroRNAs in the ionizing radiation response and in radiotherapy
Metheetrairut, C., & Slack, F. J. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.01.002 · Cited by 185
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
Liu, S.-C., Tsang, N.-M., Chiang, W.-C., Chang, K.-P., Hsueh, C., Liang, Y., Juang, J.-L., Chow, K.-P. N., & Chang, Y.-S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63428 · Cited by 184
“activation and recruitment of DDR molecules to the DSB sites (47).”
McCord, A. M., Jamal, M., Williams, E. S., Camphausen, K., & Tofilon, P. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0263 · Cited by 185
A ROS rheostat for cell fate regulation
Maryanovich, M., & Gross, A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.09.007 · Cited by 182
ATM activation in the presence of oxidative stress
Guo, Z., Deshpande, R., & Paull, T. T. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14323 · Cited by 181
MicroRNAs: new players in the DNA damage response
Hu, H., & Gatti, R. A. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq042 · Cited by 180
UFL1 promotes histone H4 ufmylation and ATM activation
Qin, B., Yu, J., Nowsheen, S., Wang, M., Tu, X., Liu, T., Li, H., Wang, L., & Lou, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-09175-0 · Cited by 183
Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?
Bradbury, A., Hall, S., Curtin, N., & Drew, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107450 · Cited by 171
Verhagen, M. M. M., Last, J. I., Hogervorst, F. B. L., Smeets, D. F. C. M., Roeleveld, N., Verheijen, F., Catsman-Berrevoets, C. E., Wulffraat, N. M., Cobben, J. M., Hiel, J., et al. (2012) · Human Mutation · doi:10.1002/humu.22016 · Cited by 174
Mukherjee, B., Tomimatsu, N., Amancherla, K., Camacho, C. V., Pichamoorthy, N., & Burma, S. (2012) · Neoplasia · doi:10.1593/neo.111512 · Cited by 168
Cellular radiosensitivity: How much better do we understand it?
Jeggo, P., & Lavin, M. F. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903261263 · Cited by 168
Self-citationMorbidity and mortality from ataxia-telangiectasia are associated with ATM genotype
Micol, R., Ben Slama, L., Suarez, F., Le Mignot, L., Beauté, J., Mahlaoui, N., Dubois d’Enghien, C., Laugé, A., Hall, J., Couturier, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.052 · Cited by 164
Riches, L. C., Trinidad, A. G., Hughes, G., Jones, G. N., Hughes, A. M., Thomason, A. G., Gavine, P., Cui, A., Ling, S., Stott, J., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1394 · Cited by 163
Radiation as an Immune Modulator
Burnette, B., & Weichselbaum, R. R. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.009 · Cited by 165
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Weil, M. K., & Chen, A. P. (2011) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2010.12.002 · Cited by 162
Tang, F. R., & Loke, W. K. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.937510 · Cited by 178
Douglas, P., Zhong, J., Ye, R., Moorhead, G. B. G., Xu, X., & Lees-Miller, S. P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00741-09 · Cited by 156
Izumi, N., Yamashita, A., Iwamatsu, A., Kurata, R., Nakamura, H., Saari, B., Hirano, H., Anderson, P., & Ohno, S. (2010) · Science Signaling · doi:10.1126/scisignal.2000468 · Cited by 181
Mechanisms that Promote and Suppress Chromosomal Translocations in Lymphocytes
Gostissa, M., Alt, F. W., & Chiarle, R. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101329 · Cited by 155
Telomere-associated aging disorders
Opresko, P. L., & Shay, J. W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.009 · Cited by 159
Genome integrity and disease prevention in the nervous system
McKinnon, P. J. (2017) · Genes & Development · doi:10.1101/gad.301325.117 · Cited by 157
Thompson, S. L., & Compton, D. A. (2010) · Chromosome Research · doi:10.1007/s10577-010-9179-y · Cited by 179
ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor
Lavin, M. F., Kozlov, S., Gatei, M. H., & Kijas, A. W. (2015) · Biomolecules · doi:10.3390/biom5042877 · Cited by 182
Self-citationThe ATM–BID pathway regulates quiescence and survival of haematopoietic stem cells
Maryanovich, M., Oberkovitz, G., Niv, H., Vorobiyov, L., Zaltsman, Y., Brenner, O. J., Lapidot, T., Jung, S., & Gross, A. (2012) · Nature Cell Biology · doi:10.1038/ncb2468 · Cited by 166
A new wave of innovations within the DNA damage response
Li, Q., Qian, W., Zhang, Y., Hu, L., Chen, S., & Xia, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01548-8 · Cited by 188
The impact of heterochromatin on DSB repair
Goodarzi, A. A., Noon, A. T., & Jeggo, P. A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370569 · Cited by 150
Reality CHEK: Understanding the biology and clinical potential of CHK1
Neizer‐Ashun, F., & Bhattacharya, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.016 · Cited by 167
Brune, K. A., & Klein, A. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_5 · Cited by 150
Katyal, S., Lee, Y., Nitiss, K. C., Downing, S. M., Li, Y., Shimada, M., Zhao, J., Russell, H. R., Petrini, J. H. J., Nitiss, J. L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3715 · Cited by 152
Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 161
Young, L. C., McDonald, D. W., & Hendzel, M. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491514 · Cited by 146
Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?
Kumar, S. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2745 · Cited by 142
Yang, Y., Xia, F., Hermance, N., Mabb, A., Simonson, S., Morrissey, S., Gandhi, P., Munson, M., Miyamoto, S., & Kelliher, M. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01139-10 · Cited by 138
Diseases Associated with Defective Responses to DNA Damage
O'Driscoll, M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012773 · Cited by 140
The ATR barrier to replication-born DNA damage
López-Contreras, A. J., & Fernandez-Capetillo, O. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.012 · Cited by 139
Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis
Guezennec, X. L., Brichkina, A. I., Huang, Y.-F., Kostromina, E. Y., Han, W., & Bulavin, D. V. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.003 · Cited by 148
53BP1 promotes ATM activity through direct interactions with the MRN complex
Lee, J., Goodarzi, A. A., Jeggo, P. A., & Paull, T. T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.372 · Cited by 164
Alcantara, D., & O’Driscoll, M. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31397 · Cited by 162
DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding zinc finger
Danielsen, J. R., Povlsen, L. K., Villumsen, B. H., Streicher, W., Nilsson, J., Wikström, M., Bekker-Jensen, S., & Mailand, N. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201106152 · Cited by 133
WIP1 phosphatase at the crossroads of cancer and aging
Guezennec, X. L., & Bulavin, D. V. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.005 · Cited by 147
NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes
Volcic, M., Karl, S., Baumann, B., Salles, D., Daniel, P., Fulda, S., & Wiesmüller, L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr687 · Cited by 133
Non-homologous end joining: Emerging themes and unanswered questions
Radhakrishnan, S. K., Jette, N., & Lees-Miller, S. P. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.01.009 · Cited by 133
Cytoplasmic ATM in Neurons Modulates Synaptic Function
Li, J., Han, Y. R., Plummer, M. R., & Herrup, K. (2009) · Current Biology · doi:10.1016/j.cub.2009.10.039 · Cited by 131
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.